版本:
中国

BRIEF-Abeona Therapeutics receives pediatric disease designation for EB-101 gene therapy product for patients with Epidermolysis Bullosa

May 30 Abeona Therapeutics Inc:

* Abeona Therapeutics receives rare pediatric disease designation for eb-101 gene therapy product for patients with Epidermolysis Bullosa Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐